DOXORUBICIN CITRATE
UNII AJQ2ZNG2WL

Substance Identification & Data

This profile provides standardized clinical and technical data for Doxorubicin Citrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AJQ2ZNG2WL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 111266-55-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AJQ2ZNG2WL
CAS Registry Number
111266-55-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DOXORUBICIN CITRATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C27H29NO11.C6H8O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
INEKNBHAPBIAFK-RUELKSSGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
C61317
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
50925403
Unique identification number in the NCBI database of chemical substances.
Substance Type
Doxorubicin citrate
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C[C@H]1[C@H]([C@H](C[C@@]([H])(O1)O[C@H]2C[C@@](Cc3c2c(c4c(C(=O)c5cccc(c5C4=O)OC)c3O)O)(C(=O)CO)O)N)O.OC(CC(CC(O)=O)(C(O)=O)O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Doxorubicin Citrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DOXORUBICIN CITRIC ACID SALT
DOXORUBICIN LIPOSOMAL COMPLEX OF THE CITRATE [MI]
Doxorubicin citrate
Doxorubicin citrate [WHO-DD]

Brand / Trade Names

MYOCET

Systematic Nomenclature

5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus
NLM
PubChem Compound